SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-039213
Filing Date
2024-05-02
Accepted
2024-05-02 17:10:28
Documents
20
Period of Report
2024-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205128-8k_tffpharma.htm   iXBRL 8-K 36685
2 FORM OF SERIES B COMMON WARRANT ea020512801ex4-1_tffpharma.htm EX-4.1 102566
3 FORM OF PRE-FUNDED WARRANT ea020512801ex4-2_tffpharma.htm EX-4.2 100883
4 FORM OF PLACEMENT AGENT WARRANT ea020512801ex4-3_tffpharma.htm EX-4.3 100737
5 FORM OF SECURITIES PURCHASE AGREEMENT ea020512801ex10-1_tffpharma.htm EX-10.1 205316
6 PRESS RELEASE DATED APRIL 29, 2024 ANNOUNCING THE PRICING OF THE OFFERING ea020512801ex99-1_tffpharma.htm EX-99.1 7044
7 PRESS RELEASE DATED MAY 1, 2024 ANNOUNCING THE CLOSING OF THE OFFERING ea020512801ex99-2_tffpharma.htm EX-99.2 6820
  Complete submission text file 0001213900-24-039213.txt   915209

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tffp-20240429.xsd EX-101.SCH 3521
9 XBRL DEFINITION FILE tffp-20240429_def.xml EX-101.DEF 26170
10 XBRL LABEL FILE tffp-20240429_lab.xml EX-101.LAB 35975
11 XBRL PRESENTATION FILE tffp-20240429_pre.xml EX-101.PRE 24798
24 EXTRACTED XBRL INSTANCE DOCUMENT ea0205128-8k_tffpharma_htm.xml XML 4634
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 24909650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)